---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-24-000060"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T18:29:41.954989+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics derivative lawsuit settled; court approves $950k fee award, dismisses claims with prejudice

## Summary
- Court approves global settlement of shareholder derivative litigation; no admission of liability.
- Company pays $950,000 in attorneys' fees and expenses; adopts corporate governance reforms.
- Consolidated Delaware derivative actions and federal derivative action dismissed with prejudice.
- Settlement relates to complaints alleging fiduciary duty breaches by former and current directors/officers.

## SEC filing metadata
- accession: 0000899923-24-000060
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992324000060/0000899923-24-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992324000060/mygn-20241126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-24-000060
- JSON: https://secwatch.observer/filing/0000899923-24-000060.json
- Plain text: https://secwatch.observer/filing/0000899923-24-000060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.